530 related articles for article (PubMed ID: 31900483)
1. CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
Schlaepfer IR; Joshi M
Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31900483
[TBL] [Abstract][Full Text] [Related]
2. Targeting CPT1A-mediated fatty acid oxidation sensitizes nasopharyngeal carcinoma to radiation therapy.
Tan Z; Xiao L; Tang M; Bai F; Li J; Li L; Shi F; Li N; Li Y; Du Q; Lu J; Weng X; Yi W; Zhang H; Fan J; Zhou J; Gao Q; Onuchic JN; Bode AM; Luo X; Cao Y
Theranostics; 2018; 8(9):2329-2347. PubMed ID: 29721083
[TBL] [Abstract][Full Text] [Related]
3. Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.
Shao H; Mohamed EM; Xu GG; Waters M; Jing K; Ma Y; Zhang Y; Spiegel S; Idowu MO; Fang X
Oncotarget; 2016 Jan; 7(4):3832-46. PubMed ID: 26716645
[TBL] [Abstract][Full Text] [Related]
4. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis.
Wolfgang MJ; Kurama T; Dai Y; Suwa A; Asaumi M; Matsumoto S; Cha SH; Shimokawa T; Lane MD
Proc Natl Acad Sci U S A; 2006 May; 103(19):7282-7. PubMed ID: 16651524
[TBL] [Abstract][Full Text] [Related]
5. Effects of cannabinoid receptor 1 (brain) on lipid accumulation by transcriptional control of CPT1A and CPT1B.
Zhang YF; Yuan ZQ; Song DG; Zhou XH; Wang YZ
Anim Genet; 2014 Feb; 45(1):38-47. PubMed ID: 23914904
[TBL] [Abstract][Full Text] [Related]
6. CPT1A-mediated fatty acid oxidation promotes cell proliferation via nucleoside metabolism in nasopharyngeal carcinoma.
Tang M; Dong X; Xiao L; Tan Z; Luo X; Yang L; Li W; Shi F; Li Y; Zhao L; Liu N; Du Q; Xie L; Hu J; Weng X; Fan J; Zhou J; Gao Q; Wu W; Zhang X; Liao W; Bode AM; Cao Y
Cell Death Dis; 2022 Apr; 13(4):331. PubMed ID: 35411000
[TBL] [Abstract][Full Text] [Related]
7. Carnitine palmitoyltransferase 1C: From cognition to cancer.
Casals N; Zammit V; Herrero L; Fadó R; Rodríguez-Rodríguez R; Serra D
Prog Lipid Res; 2016 Jan; 61():134-48. PubMed ID: 26708865
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of carnitine palmitoyl transferase 1A-induced fatty acid oxidation suppresses cell progression in gastric cancer.
Wang L; Li C; Song Y; Yan Z
Arch Biochem Biophys; 2020 Dec; 696():108664. PubMed ID: 33157102
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.
Qu Q; Zeng F; Liu X; Wang QJ; Deng F
Cell Death Dis; 2016 May; 7(5):e2226. PubMed ID: 27195673
[TBL] [Abstract][Full Text] [Related]
10. Carnitine palmitoyltransferase 1A prevents fatty acid-induced adipocyte dysfunction through suppression of c-Jun N-terminal kinase.
Gao X; Li K; Hui X; Kong X; Sweeney G; Wang Y; Xu A; Teng M; Liu P; Wu D
Biochem J; 2011 May; 435(3):723-32. PubMed ID: 21348853
[TBL] [Abstract][Full Text] [Related]
11. Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation.
Sung GJ; Choi HK; Kwak S; Song JH; Ko H; Yoon HG; Kang HB; Choi KC
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):76-81. PubMed ID: 27793752
[TBL] [Abstract][Full Text] [Related]
12. A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancer.
Hu A; Wang H; Xu Q; Pan Y; Jiang Z; Li S; Qu Y; Hu Y; Wu H; Wang X
Redox Biol; 2023 Dec; 68():102959. PubMed ID: 37977042
[TBL] [Abstract][Full Text] [Related]
13. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation.
Raud B; Roy DG; Divakaruni AS; Tarasenko TN; Franke R; Ma EH; Samborska B; Hsieh WY; Wong AH; Stüve P; Arnold-Schrauf C; Guderian M; Lochner M; Rampertaap S; Romito K; Monsale J; Brönstrup M; Bensinger SJ; Murphy AN; McGuire PJ; Jones RG; Sparwasser T; Berod L
Cell Metab; 2018 Sep; 28(3):504-515.e7. PubMed ID: 30043753
[TBL] [Abstract][Full Text] [Related]
14. CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikis.
Wang YN; Zeng ZL; Lu J; Wang Y; Liu ZX; He MM; Zhao Q; Wang ZX; Li T; Lu YX; Wu QN; Yu K; Wang F; Pu HY; Li B; Jia WH; Shi M; Xie D; Kang TB; Huang P; Ju HQ; Xu RH
Oncogene; 2018 Nov; 37(46):6025-6040. PubMed ID: 29995871
[TBL] [Abstract][Full Text] [Related]
15. CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer.
Liu Y; Wang F; Yan G; Tong Y; Guo W; Li S; Qian Y; Li Q; Shu Y; Zhang L; Zhang Y; Xia Q
Cancer Lett; 2024 Jul; 595():217006. PubMed ID: 38823763
[TBL] [Abstract][Full Text] [Related]
16. A functional gene encoding carnitine palmitoyltransferase 1 and its transcriptional and kinetic regulation during fasting in large yellow croaker.
Wang CC; Si LF; Li WY; Zheng JL
Comp Biochem Physiol B Biochem Mol Biol; 2019 May; 231():26-33. PubMed ID: 30735773
[TBL] [Abstract][Full Text] [Related]
17. Carnitine palmitoyl transferase-1A (CPT1A): a new tumor specific target in human breast cancer.
Pucci S; Zonetti MJ; Fisco T; Polidoro C; Bocchinfuso G; Palleschi A; Novelli G; Spagnoli LG; Mazzarelli P
Oncotarget; 2016 Apr; 7(15):19982-96. PubMed ID: 26799588
[TBL] [Abstract][Full Text] [Related]
18. Restoration of CPT1A-mediated fatty acid oxidation in mesothelial cells protects against peritoneal fibrosis.
Su W; Hu Z; Zhong X; Cong A; Zhang Y; Zhou Z; Li J; Su C; Huang Y; Cao W
Theranostics; 2023; 13(13):4482-4496. PubMed ID: 37649600
[No Abstract] [Full Text] [Related]
19. The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.
Virmani A; Pinto L; Bauermann O; Zerelli S; Diedenhofen A; Binienda ZK; Ali SF; van der Leij FR
Mol Neurobiol; 2015 Oct; 52(2):826-36. PubMed ID: 26041663
[TBL] [Abstract][Full Text] [Related]
20. Identifying off-target effects of etomoxir reveals that carnitine palmitoyltransferase I is essential for cancer cell proliferation independent of β-oxidation.
Yao CH; Liu GY; Wang R; Moon SH; Gross RW; Patti GJ
PLoS Biol; 2018 Mar; 16(3):e2003782. PubMed ID: 29596410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
